Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Sine Wangxiang Pharmaceutical is a prominent Chinese pharmaceutical manufacturer and a key subsidiary of the Shanghai Sine Pharmaceutical Group, which is part of the larger Shanghai Pharmaceuticals Holding (SPH). The company specializes in the production of a wide range of finished dosage forms, including tablets, capsules, and granules, with a strong focus on anti-infectives, cardiovascular medications, and gastrointestinal treatments. Operating out of modern facilities in Shanghai, the company maintains high quality standards and serves as a critical manufacturing hub for the Sine brand's extensive product portfolio. Its business model integrates research, development, and large-scale production to supply both the domestic Chinese market and international clients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Sine Wangxiang Pharmaceutical.